X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.260
-0.040 (-1.21%)
At close: Sep 12, 2025, 4:00 PM EDT
3.210
-0.050 (-1.53%)
After-hours: Sep 12, 2025, 7:53 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $73.22 million as of September 12, 2025. Its market cap has decreased by -37.93% in one year.
Market Cap
73.22M
Enterprise Value
88.29M
1-Year Change
-37.93%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has decreased from $101.77M to $73.22M, a decrease of -28.06%. That is a compound annual growth rate of -4.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 73.22M | -41.48% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | 104.72M | -39.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.08B |
| Johnson & Johnson | 422.06B |
| AbbVie | 371.84B |
| UnitedHealth Group | 313.25B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 223.01B |